Telecare — providing care to patients using a variety of communication technologies — has been touted as a win-win strategy for providers and patients that improves clinical outcomes at a lower cost. Systematic reviews have documented the benefits of telecare in several populations including patients with pulmonary disease, diabetes, heart disease, and hypertension.1-4 Like other chronic illnesses, chronic musculoskeletal pain is common, difficult to manage, and costly.... Read More
In these multimedia presentations, our moderator reviews a research manuscript and an expert panel discusses its strengths, weaknesses, and potential implications for practice.
Succinct reviews that discuss the potential impact of recently published manuscripts on ambulatory care pharmacy practice. Read the commentaries and voice your own opinions.
Featured Panel Discussion
This is a brief review of the CANTATA-SU trial and a discussion about the role of sodium glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.
Are medications in this new class of agents something we should consider earlier in the treatment of type 2 diabetes? Or perhaps even for the treatment of type 1 diabetes? Are you concerned about their adverse effects and long-term safety? Tell us what you think by posting a comment.